Beckman Coulter’s Immunoassay Analyzer Extends Menu with Hepatitis Assays
Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.
Read MorePosted by Andy Lundin | Apr 19, 2024 | Immunoassay Instrumentation |
Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.
Read MorePosted by Andy Lundin | Mar 7, 2024 | Sexually Transmitted Diseases |
Thee American Medical Association launched a new toolkit to help increase screenings for HIV, STIs, viral hepatitis and latent tuberculosis.
Read MorePosted by Andy Lundin | Feb 21, 2024 | Sepsis |
This method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.
Read MorePosted by Chris Wolski | Feb 1, 2024 | Emerging & Zoonotic Diseases |
Picodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read MorePosted by Andy Lundin | Jan 11, 2024 | Infectious Diseases |
Wastewater surveillance is a potent tool in understanding COVID transmission within school settings, according to a new study.
Read More